| Excitotoxic neuronal death and the pathogenesis of Huntington's disease AME Sánchez, J Mejía-Toiber, L Massieu Archives of medical research 39 (3), 265-276, 2008 | 267 | 2008 |
| Glutamate toxicity in the striatum of the R6/2 Huntington's disease transgenic mice is age-dependent and correlates with decreased levels of glutamate transporters AM Estrada-Sánchez, T Montiel, J Segovia, L Massieu Neurobiology of disease 34 (1), 78-86, 2009 | 117 | 2009 |
| Role of cerebral cortex in the neuropathology of Huntington's disease AM Estrada-Sánchez, GV Rebec Frontiers in neural circuits 7, 19, 2013 | 105 | 2013 |
| Corticostriatal dysfunction and glutamate transporter 1 (GLT1) in Huntington’s disease: interactions between neurons and astrocytes AM Estrada-Sánchez, GV Rebec Basal ganglia 2 (2), 57-66, 2012 | 98 | 2012 |
| Activation of NOX2 by the stimulation of ionotropic and metabotropic glutamate receptors contributes to glutamate neurotoxicity in vivo through the production of reactive … A Guemez-Gamboa, AM Estrada-Sánchez, T Montiel, B Páramo, ... Journal of Neuropathology & Experimental Neurology 70 (11), 1020-1035, 2011 | 79 | 2011 |
| Differential effects of the substrate inhibitor L-trans-pyrrolidine-2, 4-dicarboxylate (PDC) and the non-substrate inhibitor DL-threo-β-benzyloxyaspartate (DL-TBOA) of … T Montiel, A Camacho, AM Estrada-Sanchez, L Massieu Neuroscience 133 (3), 667-678, 2005 | 76 | 2005 |
| Cortical efferents lacking mutant huntingtin improve striatal neuronal activity and behavior in a conditional mouse model of Huntington's disease AM Estrada-Sánchez, CL Burroughs, S Cavaliere, SJ Barton, S Chen, ... Journal of Neuroscience 35 (10), 4440-4451, 2015 | 61 | 2015 |
| Pathways involved in the generation of reactive oxygen and nitrogen species during glucose deprivation and its role on the death of cultured hippocampal neurons B Páramo, K Hernández-Fonseca, AM Estrada-Sánchez, N Jimenez, ... Neuroscience 167 (4), 1057-1069, 2010 | 61 | 2010 |
| Heme oxygenase-1 induction prevents neuronal damage triggered during mitochondrial inhibition: role of CO and bilirubin M Orozco-Ibarra, AM Estrada-Sánchez, L Massieu, J Pedraza-Chaverrí The International Journal of Biochemistry & Cell Biology 41 (6), 1304-1314, 2009 | 43 | 2009 |
| Quantitative electroencephalographic biomarkers in preclinical and human studies of Huntington’s disease: are they fit-for-purpose for treatment development? MK Leuchter, EJ Donzis, C Cepeda, AM Hunter, AM Estrada-Sánchez, ... Frontiers in neurology 8, 223305, 2017 | 32 | 2017 |
| Neuronal network topology indicates distinct recovery processes after stroke S Latifi, S Mitchell, R Habibey, F Hosseini, E Donzis, AM Estrada-Sánchez, ... Cerebral Cortex 30 (12), 6363-6375, 2020 | 25 | 2020 |
| Neural deletion of glucose transporter isoform 3 creates distinct postnatal and adult neurobehavioral phenotypes BC Shin, C Cepeda, AM Estrada-Sánchez, MS Levine, L Hodaei, Y Dai, ... Journal of Neuroscience 38 (44), 9579-9599, 2018 | 24 | 2018 |
| Cortical network dynamics is altered in mouse models of Huntington’s disease EJ Donzis, AM Estrada-Sánchez, T Indersmitten, K Oikonomou, CH Tran, ... Cerebral Cortex 30 (4), 2372-2388, 2020 | 23 | 2020 |
| Glycolysis inhibition decreases the levels of glutamate transporters and enhances glutamate neurotoxicity in the R6/2 Huntington′ s disease mice AM Estrada-Sánchez, T Montiel, L Massieu Neurochemical Research 35, 1156-1163, 2010 | 22 | 2010 |
| Revealing the contribution of astrocytes to glutamatergic neuronal transmission AO Cuellar-Santoyo, VM Ruiz-Rodríguez, TB Mares-Barbosa, ... Frontiers in Cellular Neuroscience 16, 2023 | 19 | 2023 |
| Chemoresistance in Breast Cancer Patients Associated With Changes in P2X7 and A2A Purinergic Receptors in CD8+ T Lymphocytes VM Ruiz-Rodríguez, E Turiján-Espinoza, JA Guel-Pañola, ... Frontiers in Pharmacology 11, 576955, 2020 | 13 | 2020 |
| Dysregulated corticostriatal activity in open-field behavior and the head-twitch response induced by the hallucinogen 2, 5-dimethoxy-4-iodoamphetamine C Rangel-Barajas, AM Estrada-Sánchez, SJ Barton, RR Luedtke, ... Neuropharmacology 113, 502-510, 2017 | 10 | 2017 |
| Dysregulated striatal neuronal processing and impaired motor behavior in mice lacking huntingtin interacting protein 14 (HIP14) AM Estrada-Sánchez, SJ Barton, CL Burroughs, AR Doyle, GV Rebec PLoS One 8 (12), e84537, 2013 | 10 | 2013 |
| Epilepsy in other neurodegenerative disorders: Huntington’s and Parkinson’s diseases AM Estrada-Sánchez, MS Levine, C Cepeda Models of seizures and epilepsy, 1043-1058, 2017 | 9 | 2017 |
| Complete but not partial inhibition of glutamate transporters exacerbates cortical excitability in the R6/2 mouse model of Huntington’s disease AM Estrada‐Sánchez, D Castro, K Portillo‐Ortiz, K Jang, M Nedjat‐Haiem, ... CNS neuroscience & therapeutics 25 (4), 509-518, 2019 | 8 | 2019 |
Montiel TTecnico académicoVerified email at ifc.unam.mx
